Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
Go back to Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm| StemCells, Inc. (NASDAQ: TEM) | Delayed: 48.94 -1.9 (3.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.84 | 52 Week High | $0.45 | |||
| Open | $49.75 | 52 Week Low | $0.37 | |||
| Day High | $51.27 | P/E | N/A | |||
| Day Low | $47.64 | EPS | $-0.31 | |||
| Volume | 2,957,859 | |||||

